•  
  •  
  •  
  •  

2025-08-08 22:04:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  Japan

Stock Report

  • Anupam Rasayan Signs Master Purchase Agreement with Japanese Multinational Conglomerate, Expanding Strategic Reach in Japan
  • Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan
  • Standard Glass Lining Technology Ltd Forms Strategic Partnership with Japan's AGI Group
  • Ami Organics Limited, Unit II, Ankleshwar Unit in Gujarat is GMP compliant Unit by PMDA Japan
  • Mitsubishi Heavy Industries joins Infosys-led JV in Japan, HIPUS
  • Uno Minda gears up for Sunroof Growth in India with Aisin, Japan Partnership
  • Fiem Industries Ltd opens new R&D Center
  • Tanfac Industries Ltd signs framework agreement with Japanese Specialty Chemical worth ~$81 Mn
  • Ami Organics'Limited, Unit I, Sachin, Surat in Gujarat has cleared PMDA Japan, GMP Inspection
  • Infosys collaborates with Nihon Chouzai to expand healthcare access in Japan
  • Amara Raja Energy & Mobility wins excellence awards for plant maintenance in Japan
  • Spark Minda enters into a strategic alliance with Global Japanese Player for manufacturing of Smart Vehicle Access Systems
  • Anupam Rasayan signs LoI worth $61 Million with one of the Leading Japanese MNC Chemical Company
  • Anupam Rasayan India Forays in Japan with Wholly Owned Subsidiary 'Anupam Japan GK'
  • Shilpa Pharma Lifesciences Ltd, Unit II, Raichur, Karnataka has cleared PMDA Japan, GMP inspection
  • Granules India Limited received Accreditation Certificate of Foreign Drug Manufacturer from PMDA
  • Kings Infra set to close major export deals with US, Japan & China
  • Anupam Rasayan signs LOI worth $265 Million with one of the Leading Japanese Speciality Chemical Company
  • IndusInd Bank signs USD 100 million loan agreement with JBIC to facilitate the growth of Japanese Construction Equipment Companies in India
  • Anupam Rasayan signs Letter of Intent worth $182 Million with one of the Leading Japanese Multinational
  • Alps Alpine and Tata Elxsi announce a strategic long-term agreement for growing vehicle software development sectors
  • Anupam Rasayan signs LoI worth $120 Million with one of the Leading Japanese Chemical Company
  • L&T Construction awarded yet another contract in the Bullet Train Project
  • Thomas Cook India & SOTC Travel launch curated range of experiential Japan Holidays Ahead of Cherry Blossom season

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024